Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - Other
Ratios

Bristol Myers Squibb (BMYMP) Receivables - Other (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Receivables - Other for 17 consecutive years, with $192.0 million as the latest value for Q4 2025.

  • Quarterly Receivables - Other fell 88.93% to $192.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $192.0 million through Dec 2025, down 88.93% year-over-year, with the annual reading at $192.0 million for FY2025, 88.93% down from the prior year.
  • Receivables - Other for Q4 2025 was $192.0 million at Bristol Myers Squibb, down from $224.0 million in the prior quarter.
  • The five-year high for Receivables - Other was $2.2 billion in Q1 2023, with the low at $192.0 million in Q4 2025.
  • Average Receivables - Other over 5 years is $1.2 billion, with a median of $1.4 billion recorded in 2021.
  • The sharpest move saw Receivables - Other soared 380.61% in 2022, then plummeted 88.93% in 2025.
  • Over 5 years, Receivables - Other stood at $361.0 million in 2021, then skyrocketed by 380.61% to $1.7 billion in 2022, then rose by 17.52% to $2.0 billion in 2023, then dropped by 14.91% to $1.7 billion in 2024, then crashed by 88.93% to $192.0 million in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $192.0 million, $224.0 million, and $1.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.